Showing results (591-600 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|August 11, 2018
Approaches to Direct Oral Anticoagulant Selection in PracticeBridget Paravattil, Hazem ElewaJournal of Cardiovascular Pharmacology and Therapeutics|September 17, 2016
The Role of MicroRNA and LncRNA-MicroRNA Interactions in Regulating Ischemic Heart DiseaseNa Li, Murugavel Ponnusamy, Meng-Peng Li, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 5, 2010
Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blockerHirotsugu Yamada, Yuichiro Mishiro, Kenya Kusunose, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to BedsideJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 12, 2009
Differential effects of oral beta blockade on cardiovascular and sympathetic regulationS P Beloka, S Gouveia, M Gujic, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 12, 2009
Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteriesYan Wang, MingSheng Zhang, Yu Liu, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 8, 2009
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapyHarit Desai, Wilbert S Aronow, Chul Ahn, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 10, 2018
Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) RatFiras Younis, Jonathan Leor, Zaid Abassi, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 20, 2018
Impact of Chronic Antiplatelet Therapy on Infarct Size and Bleeding in Patients With Acute Myocardial InfarctionJeness Campodonico, Nicola Cosentino, Valentina Milazzo, et al.Pageof 129